|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goggins WB and Wong GK: Poor survival for
US Pacific Islander cancer patients: Evidence from the
surveillance, epidemiology, and end results database: 1991 to 2004.
J Clin Oncol. 25:5738–5741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Japanese Gastric Cancer Association, .
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric
Cancer. 14:113–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schwarz RE and Smith DD: Clinical impact
of lymphadenectomy extent in resectable gastric cancer of advanced
stage. Ann Surg Oncol. 14:317–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith DD, Schwarz RR and Schwarz RE:
Impact of total lymph node count on staging and survival after
gastrectomy for gastric cancer: Data from a large US-population
database. J Clin Oncol. 23:7114–7124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eom BW, Joo J, Kim YW, Reim D, Park JY,
Yoon HM, Ryu KW, Lee JY and Kook MC: Improved survival after adding
dissection of the superior mesenteric vein lymph node (14v) to
standard D2 gastrectomy for advanced distal gastric cancer.
Surgery. 155:408–416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feinstein AR, Sosin DM and Wells CK: The
Will Rogers phenomenon. Stage migration and new diagnostic
techniques as a source of misleading statistics for survival in
cancer. N Engl J Med. 312:1604–1608. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seevaratnam R, Bocicariu A, Cardoso R,
Yohanathan L, Dixon M, Law C, Helyer L and Coburn NG: How many
lymph nodes should be assessed in patients with gastric cancer? A
systematic review. Gastric Cancer. 15 Suppl 1:S70–S88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hartgrink HH, van de Velde CJ, Putter H,
Bonenkamp JJ, Kranenbarg E Klein, Songun I, Welvaart K, van Krieken
JH, Meijer S, Plukker JT, et al: Extended lymph node dissection for
gastric cancer: Who may benefit? Final results of the randomized
Dutch gastric cancer group trial. J Clin Oncol. 22:2069–2277. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuschieri A, Weeden S, Fielding J,
Bancewicz J, Craven J, Joypaul V, Sydes M and Fayers P: Patient
survival after D1 and D2 resections for gastric cancer: Long-term
results of the MRC randomized surgical trial. Surgical Co-operative
Group. Br J Cancer. 79:1522–1530. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Songun I, Putter H, Kranenbarg EM, Sasako
M and van de Velde CJ: Surgical treatment of gastric cancer:
15-year follow-up results of the randomised nationwide Dutch D1D2
trial. Lancet Oncol. 11:439–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sierra A, Regueira FM, Hernández-Lizoáin
JL, Pardo F, Martínez-Gonzalez MA and A-Cienfuegos J: Role of the
extended lymphadenectomy in gastric cancer surgery: Experience in a
single institution. Ann Surg Oncol. 10:219–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Degiuli M, Sasako M, Calgaro M, Garino M,
Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A and Calvo
F; Italian Gastric Cancer Study Group, : Morbidity and mortality
after D1 and D2 gastrectomy for cancer: Interim analysis of the
Italian Gastric Cancer Study Group (IGCSG) randomised surgical
trial. Eur J Surg Oncol. 30:303–308. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Degiuli M, Sasako M, Ponti A and Calvo F:
Survival results of a multicentre phase II study to evaluate D2
gastrectomy for gastric cancer. Br J Cancer. 90:1727–1732. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zong L, Abe M, Seto Y and Ji J: Randomized
controlled trial of laparoscopic versus open D2 distal gastrectomy
for advanced gastric cancer: How should we define the age of
included patents? J Clin Oncol. Aug 9–2016.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bozzetti F, Marubini E, Bonfanti G, Miceli
R, Piano C and Gennari L: Subtotal versus total gastrectomy for
gastric cancer: Five-year survival rates in a multicenter
randomized Italian trial. Italian Gastrointestinal Tumor Study
Group. Ann Surg. 230:170–178. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galizia G, Lieto E, De Vita F, Castellano
P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De
Stefano L, et al: Modified versus standard D2 lymphadenectomy in
total gastrectomy for nonjunctional gastric carcinoma with lymph
node metastasis. Surgery. 157:285–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Galizia G, Lieto E, Zamboli A, Auricchio A
and Orditura M: Reply ‘Modified D2 lymphadenectomy is effective in
patients with node-positive gastric cancers undergoing potentially
curative total gastrectomy’. Surgery. 158:1447–1448. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karpeh MS, Leon L, Klimstra D and Brennan
MF: Lymph node staging in gastric cancer: Is location more
important than Number? An analysis of 1,038 patients. Ann Surg.
232:362–371. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Enzinger PC, Benedetti JK, Meyerhardt JA,
McCoy S, Hundahl SA, Macdonald JS and Fuchs CS: Impact of hospital
volume on recurrence and survival after surgery for gastric cancer.
Ann Surg. 245:426–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Degiuli M, Sasako M and Ponti A; Italian
Gastric Cancer Study Group, : Morbidity and mortality in the
Italian Gastric Cancer Study Group randomized clinical trial of D1
versus D2 resection for gastric cancer. Br J Surg. 97:643–649.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Degiuli M, Sasako M, Ponti A, Vendrame A,
Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G and Morino M;
Italian Gastric Cancer Study Group, : Randomized clinical trial
comparing survival after D1 or D2 gastrectomy for gastric cancer.
Br J Surg. 101:23–31. 2014. View
Article : Google Scholar : PubMed/NCBI
|
